Microbiology
-
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
This article has 11 authors:Reviewed by ScreenIT
-
Lopinavir-ritonavir is not an effective inhibitor of the main protease activity of SARS-CoV-2 in vitro
This article has 7 authors:Reviewed by ScreenIT
-
Elucidating the antiviral mechanism of different MARCH factors
This article has 6 authors:Reviewed by ScreenIT
-
Methylene Blue has a potent antiviral activity against SARS-CoV-2 in the absence of UV-activation in vitro
This article has 6 authors:Reviewed by ScreenIT
-
Effect of mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion function
This article has 10 authors:Reviewed by ScreenIT
-
A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters
This article has 19 authors:Reviewed by ScreenIT
-
A soluble ACE2 microbody protein fused to a single immunoglobulin Fc domain is a potent inhibitor of SARS-CoV-2 infection in cell culture
This article has 7 authors:Reviewed by ScreenIT
-
The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers
This article has 3 authors:Reviewed by ScreenIT
-
3D reconstruction of SARS-CoV-2 infection in ferrets emphasizes focal infection pattern in the upper respiratory tract
This article has 10 authors:Reviewed by ScreenIT
-
Codon usage pattern reveals SARS-CoV-2 as a monomorphic pathogen of hybrid origin with role of silent mutations in rapid evolutionary success
This article has 3 authors:Reviewed by ScreenIT